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Olivier Goëau-Brissonniere, MD, PhD, and Marc Coggia, MD, Boulogne-Billancourt and
Montigny-le-Bretonneux, France
Objective: The radial approach is currently gaining popularity in the setting of coronary percutaneous transluminal an-
gioplasty (PTA) because it decreases the incidence of vascular complications. This study reports our initial results with
radial access for peripheral PTA.
Methods: Between November 2011 and January 2014, we performed peripheral PTA in 526 patients. PTA was performed
through left radial access in 24 ambulatory patients (4.6%) presenting with TransAtlantic Inter-Society Consensus A or B
lesions on preoperative computed tomography angiography. Materials included a 110-cm-long introducer, a 0.018-inch
400-cm-long wire, 150-cm-long angiography catheters, 180-cm-long shaft balloons and stents. Data were prospectively
collected.
Results: There were 22 men (92%), median age was 65 years (range, 45-88 years), and 38 target lesions were treated.
Indication for revascularization was disabling claudication in 22 patients (92%) and critical ischemia in two (8%). Indi-
cation for choosing the radial approach was bilateral hostile groins in 12 patients (50%), bilateral infrainguinal lesions in 4
(17%), need for a contralateral femoral approach in the setting of kissing iliac stents or bifurcated surgical aortic grafts in
3 (13%), and elective in 5 (21%). Radial puncture failed in one patient (4%), and PTA was performed through brachial
access. Technical success was 91% (20 of 22 patients). Thirty-seven stents were implanted. Total procedure duration was
45 minutes (range, 30-120 minutes). Fluoroscopy time was 9 minutes (range, 5-35 minutes), and 40 mL (range, 20-
90 mL) of contrast was necessary. Radial artery rupture secondary to spasm was noted at the end of the procedure in two
patients (8%). All patients could ambulate 2 hours after the procedure. No patient died. Median follow-up was 8 months
(range, 1-23 months). Three radial arteries (13%) were occluded at the last follow-up. At 6 months, freedom from target
lesion revascularization and target vessel revascularization were 91% and 91%, respectively, for iliac lesions and 93% and
86%, respectively, for infrainguinal lesions.
Conclusions: This study demonstrates the feasibility of radial access for peripheral PTA. Radial access could represent an
alternative to brachial access for peripheral and visceral interventions. Although complication rates of the present series are
concerning, larger studies are needed to determine the role of transradial PTA once the learning curve is overcome. A wider
diffusion of the technique mandates (1) smaller-diameter sheaths, (2) longer shaft devices, and (3) the development of
speciﬁcally designed rescue devices such as covered stents and thromboaspiration catheters. (J Vasc Surg 2015;61:463-8.)In the current period, the main vascular access for pe-
ripheral percutaneous transluminal angioplasty (PTA) is the
common femoral artery (CFA). In some situations, the
CFA can be inappropriate or unavailable for puncture,
such as in the absence of palpable femoral pulses, the pres-
ence of CFA calciﬁcations, obesity, a history of femoral sur-
gery (particularly with prosthetic materials), or the need for
a contralateral femoral approach in the setting of previous
kissing iliac stents or a bifurcated aortic graft.the Service de Chirurgie Vasculaire, Hôpital Universitaire Ambroise
ré, Assistance PubliquedHôpitaux de Paris (AP-HP), Boulogne-Bill-
court; and Faculté de Médecine Paris-Ile de France-Ouest, UFR des
iences de la santé Simone Veil, Université Versailles Saint-Quentin en
elines, Montigny-le-Bretonneux.
or conﬂict of interest: none.
rint requests: Raphaël Coscas, MD, Service de Chirurgie Vasculaire,
ôpital Universitaire Ambroise Paré, 9 avenue Charles de Gaulle,
104 Boulogne Cedex, France (e-mail: rcoscas@gmail.com).
editors and reviewers of this article have no relevant ﬁnancial relationships
disclose per the JVS policy that requires reviewers to decline review of any
anuscript for which they may have a conﬂict of interest.
-5214
yright  2015 by the Society for Vascular Surgery.
://dx.doi.org/10.1016/j.jvs.2014.07.009Access through the upper limb, especially from the
brachial artery, has been well described as an additional,1,2
or main1,3-5 access in these situations but is fraught with
risks of local complications (pseudoaneurysm, brachial ar-
tery thrombosis, median nerve injury) in up to 11%
cases.1,3-5 The radial approach is currently gaining popu-
larity in the setting of coronary PTA.6,7 It is associated
with fewer vascular complications compared with femoral
access.6-11 A recent meta-analysis8 of randomized
controlled trials comparing radial vs femoral access for pri-
mary percutaneous coronary interventions (PCIs) revealed
that the radial approach was signiﬁcantly associated with a
decreased risk of major bleeding (1.4% vs 2.9%) and access
site bleeding (2.1% vs 5.6%). Scant data are available
regarding the use of this alternative approach in peripheral
PTA.12-16 The aim of this study was to report our initial re-
sults with radial access for peripheral PTA.
METHODS
Ethics Committee approval was not necessary for this
study because the study only involved Conformité
Européene-approved medical devices, no new implantable
materials, and already described access techniques. The463
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Helsinki.
Patient selection and preoperative assessment. Be-
tween November 2011 and January 2014, we performed
526 peripheral PTAs. Of these, 24 nonconsecutive ambu-
latory patients (4.6%) presenting with TransAtlantic
Inter-Society Consensus (TASC) A or B lesions on pre-
operative computed tomography angiography (CTA) un-
derwent a PTA through left radial access (LRA). During
the same period, we used brachial access in six patients
(1.1%) and axillary access in three (0.6%).
Decision making to perform transradial access was at
each senior surgeon’s discretion and usually depended on
material availability, patient choice, and the surgeon’s
expertise. Patients with a history of aortic arch atheroemb-
olism and stage $3 chronic kidney disease (glomerular
ﬁltration rate <60 mL/min) were not offered a radial
approach.
Preoperatively, the left arm was examined and the pres-
ence of ulnar and radial pulses was veriﬁed. An Allen test
was systematically performed, and an alternative access
(femoral or brachial) was used if the Allen test result was
negative. All patients gave informed consent for the
procedure.
Operative technique. The procedure took place in the
operating room. The patient was placed supine with the
right upper limb along the body and the left upper limb
perpendicular to the body axis. The mobile C-arm (Vera-
dius Neo; Philips Healthcare, Best, The Netherlands) was
placed at the patient’s right side. The operator and the as-
sistant stood at the level of the left wrist, and the ﬂuoro-
scopic screen was positioned in front of them. The left
upper limb and both groins were draped.
Retrograde puncture of the radial artery was performed
using a 21-gauge needle from a transpedal puncture kit
(Cook Inc, Bloomington, Ind). Heparin was administered
intravenously (50 IU/kg). A short 4F introducer (Terumo
Europe, Leuven, Belgium) was introduced in the radial ar-
tery. A 0.035-inch 260-cm-long hydrophilic guidewire
(Terumo Europe) was pushed to the level of the left sub-
clavian ostium. A C2 or a pigtail catheter (Cook Inc) was
used to catheterize the descending aorta, and the wire
was exchanged for a 0.035-inch 260-cm-long Amplatz su-
per stiff wire (Boston Scientiﬁc, Natick, Mass). This
allowed changing the introducer for a 110-cm-long sheath
(Cook Inc), which was pushed down to the level of the
aortic bifurcation.
When iliac angioplasty and stenting was planned, we
used a 6F introducer, and a 5F introducer was used for su-
perﬁcial femoral artery (SFA) treatment. A 125-cm-long
vertebral catheter (Cook Inc) was used to catheterize the
ipsilateral common iliac artery. After this maneuver, the
introducer was pushed into the ipsilateral common iliac ar-
tery and even into the external iliac artery, when possible. If
the ipsilateral CIA presented a tight stenosis, balloon an-
gioplasty was performed ﬁrst.
Iliac angioplasty. Iliac angioplasty was performed us-
ing 135-cm-long shafts Express LD (Boston Scientiﬁc)stents. When a stent diameter >8 mm was needed, we
implanted 8-mm-diameter stents and then inﬂated them
using a 9- or 10-mm-diameter 135-cm-long shaft Fox
balloon (Abbott Vascular, Redwood City, Calif) because
the Express LD stents >8 mm in diameter enter a 7F
sheath.
SFA angioplasty. SFA angioplasty mandated even
longer material. The 0.035-inch guidewire was exchanged
for a 400-cm-long 0.018-inch Plywire guidewire (Optimed
Global Care, Ettlingen Germany). Catheterization of the
lesion could necessitate the use of 150-cm-long 4F straight
or beacon tip Slip-cath angiography catheters (Cook Inc).
Angioplasty was performed using a 180-cm-long shaft Pa-
ciﬁc Xtreme angioplasty balloon (Medtronic Invatec,
Frauenfeld, Switzerland). When a stent was needed, we used
a 180-cm-long shaft Sinus-SuperFlex-518 stent (Optimed
Global Care). Stent modeling was performed using the
balloon previously described.
After completion angiography, the wires and the
sheath were retrieved. Manual arterial compression was
performed for 10 minutes. The TR Band radial artery
compression device (Terumo Europe) was positioned and
removed 6 hours later.
Postoperative management and follow-up. All pa-
tients were asked to walk 2 hours after the procedure. After
removal of the radial artery compression device, radial pulse
and hand coloration were veriﬁed, and patients were dis-
charged home. An oral antiplatelet agent (aspirin [75-
250 mg] or clopidogrel [75 mg], daily) and statin therapy
were administered to all patients before the procedure and
continued for life-long. Patients were examined at the 1-
month visit with a duplex scan of the lower and the left
upper limbs. Biannual follow-up visits were planned
thereafter.
Data collection. Data were collected prospectively in a
computerized database. Results are presented as median
and range.
RESULTS
Study population. There were 22 men (92%) and two
women (8%), aged 65 years (range, 45-88 years). Median
patient height was 171 cm (range, 155-183 cm). Indica-
tion for revascularization was disabling claudication in 22
patients (92%) and critical limb ischemia in two (8%). All
lesions were classiﬁed as TASC A or B on preoperative
CTA. Risk factors and comorbidities are presented in
Table I.
Indications for choosing a radial approach in these pa-
tients are reported in Table II. Bilateral hostile groins
(obesity, history of bilateral femoral surgery) were noted
in 12 patients (50%). After the 15 ﬁrst cases, LRA was
used electively in ﬁve patients (21%).
Technique. Radial puncture failed in one patient (4%)
because of major refractory radial artery spasm (RAS), and
the procedure was successfully performed through percuta-
neous brachial access. In another patient (4%), a 9-cm-long
SFA occlusion could not be crossed, and the procedure was
undertaken through femoral access. There were 38 target
Table I. Baseline characteristics of patients
Variables
Median (range) or No. (%)
(n ¼ 24)
Demographics
Age, years 65 (45-88)
Male gender 22 (88)
Height, cm 171 (155-183)
Risk factors
Tobacco use 19 (79)
Hypertension 18 (75)
Hyperlipidemia 18 (75)
Diabetes 6 (25)
Obesity (BMI >30 kg/m2) 4 (17)
Patient characteristics
Coronary artery disease 9 (38)
Bilateral hostile groins 12 (50)
ASA class 3 or 4 13 (54)
Indication and disease characteristics
Disabling claudication 22 (92)
Critical limb ischemia 2 (8)
TASC A lesion 17 (71)
TASC B lesion 7 (29)
ASA class, American Society of Anesthesiologists Physical Status Classiﬁca-
tion; BMI, body mass index; TASC, TransAtlantic Inter-Society Consensus.
Table II. Indications for choosing a radial approach in
the present series
Indication No. (%)
Bilateral hostile groins, including 12 (50)
History of bilateral femoral surgery 9 (38)
Obesity 3 (13)
Bilateral infrainguinal lesions 4 (17)
Contralateral femoral approach needed in the setting of
kissing iliac stents or bifurcated surgical aortic grafts
3 (13)
Elective 5 (21)
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SFAs (45%), and 3 popliteal arteries (8%). Thirty-seven
stents were implanted. Technical success was 91% (20 of
22 patients).
Total procedure duration was 45 minutes (range, 30-
120 minutes). Fluoroscopy time was 9 minutes (range, 5-
35 minutes), and 40 mL (range, 20-90 mL) of contrast
was necessary. Of note, ﬂuoroscopy time decreased
through the study period, which highlights the importance
of the learning curve process with this approach. Fluoros-
copy time was 15 minutes (range, 8-35 minutes) for the
ﬁrst 12 patients and was 8 minutes (range 5-13 minutes)
for the second half of the series.
Left radial artery rupture was noted at the end of the
procedure in two patients (8%), mandating compression
therapy. We tried to seal the rupture in both patients using
a 6F introducer that was let in place in the artery for
15 minutes. After the device was removed, the rupture
was still present in both patients, and we used manual
compression for 10 minutes. A hemostatic band was then
applied over the forearm for 2 hours.All patients were able to walk 2 hours after the PTA. In
total, 15 patients (63%) were discharged home the day of
the procedure. The ﬁrst ﬁve patients of the series stayed
overnight in the hospital as a precaution. The two patients
with radial artery rupture were also kept overnight in the
hospital for surveillance. Two more patients had social is-
sues precluding an early discharge.
Perioperative complications. An 87-year-old woman
(4%) presented a minor right hemispheric postoperative
stroke (Rankin score 2) at the ﬁrst postoperative day, from
which she recovered. No other complications were noted.
Apart from the two patients with radial rupture, all patients
had a left radial pulse at discharge. All early complications
occurred in the ﬁrst 12 patients of the series.
Follow-up. With a median 8 months of follow-up
(range, 1-23 months), three patients underwent reopera-
tions. The ﬁrst patient presented 3 months after the pro-
cedure with recurrent claudication related to iliac stent
thrombosis. He was successfully treated by percutaneous
recanalization through femoral access. However, he ﬁnally
developed diffuse iliac lesions and underwent laparoscopic
aortobifemoral bypass at 21 months. The second patient
underwent SFA angioplasty proximal to the last PTA
because of a new symptomatic stenosis at 5 months. He
also ﬁnally developed diffuse SFA lesions and underwent
femoropopliteal bypass at 19 months. The third patient
had redo-PTA at 6 months related to intrastent restenosis.
At 6 months, freedom from target lesion revascularization
and target vessel revascularization were 91% and 91%,
respectively, for iliac lesions and 93% and 86%, respectively,
for infrainguinal lesions.
In addition to the two patients who had intraoperative
radial artery rupture and a subsequently occluded radial ar-
tery, one more patient was noted to have left radial artery
thrombosis at the 1-month duplex scan examination.
Therefore, three radial arteries (13%) were found to be
occluded at the last follow-up. The other patients were
alive and healthy, with satisfactory PTA patency on their
last duplex scan examination.
DISCUSSION
This study demonstrates the feasibility of peripheral
PTA through LRA and also highlights some drawbacks
and limits of this technique. In the current era, the femoral
artery is considered as the ﬁrst-choice access site for periph-
eral PTA. Although this approach is usually simple and fast
to perform, several issues remain. The femoral artery can be
hard to puncture, even when using duplex scan guidance,
especially in the setting of obese patients or antegrade ac-
cess.17 In some cases, femoral artery puncture can be
deemed at increased risk of local complications or failure,
such as in the absence of palpable femoral pulses, the pres-
ence of CFA calciﬁcations, obesity, a history of femoral sur-
gery (especially with prosthetic materials), or the need for a
contralateral femoral approach in the setting of previous
kissing iliac stents or a bifurcated aortic graft. Moreover,
postoperative hematomas account for signiﬁcant postoper-
ative morbidity.17,18
Table III. Preferred lesions and indications for peripheral transluminal angioplasty (PTA) through a radial approach
Lesions Indications Contraindications
TASC A or B History of bilateral femoral surgery (prosthetic grafts) Negative Allen test
Stenosis rather than occlusion Cross-over needed in the setting of previous
iliac kissing stents or bifurcated aortic graft
Aortic arch atherothrombosis
Short-length lesion Bilateral SFA lesions Functional arteriovenous ﬁstula
Above-knee lesion Obesity Hemodialysis vascular access needed
No palpable femoral pulses Long height/amplitude
Need for high dose of antithrombotic therapy
SFA, Superﬁcial femoral artery; TASC, TransAtlantic Inter-Society Consensus.
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complications derive from the coronary literature.6-11 In the
prospective multicenter RIVAL (Radial vs Femoral Access
for Coronary Angiography and Intervention in Patients
With Acute Coronary Syndromes ) study,11 rates of major
vascular complications (large hematomas, pseudoaneurysm
needing closure, arteriovenous ﬁstula) and minor bleeding
with femoral access were 3.7% and 3.4%, respectively.
Another issue with femoral access is the need for pa-
tients to stay supine several hours after the procedure.19,20
Early ambulation after femoral artery puncture is
feasible,20-24 especially when using vascular closure devices.
In our study, we kept our patients supine for 2 hours after
the procedure as a precaution. No patient had any access
site bleeding complication during this time. Therefore,
we think that LRA allows ambulation with totally normal
walking activities immediately after the procedure. This
aspect may facilitate outpatient procedures and simplify
postoperative surveillance.
Radial access is gaining popularity for PCIs.6,7 In
France, more than half of PCIs are performed through
radial access.25 In the United States, radial access repre-
sented 16% of PCI by the end of 2012 but was used
in <2% of PCI in 2007.7 Although reasons for this modi-
ﬁcation of practice can be multiple, the decrease in local
complications6,7 and the ability to simplify outpatient pro-
cedures might explain the rise of radial access in PCI.
Whether results of transradial coronary interventions can
be transferred to peripheral PTA remains uncertain.12-16
In the coronary literature, sizes of sheaths, transarterial nav-
igation, and antithrombotic regimen are different
compared with peripheral PTA. For these reasons, we
designed this study to assess the feasibility and evaluate
the results of radial access for peripheral PTA.
Our results allowed us to improve patient selection for
transradial peripheral PTA. We recommend systematically
performing a preoperative Allen test. During the study
period, we excluded two patients due to a negative Allen
test. It could be of great interest to consider the use of a
vascular laboratory to perform the Allen test and map the
course of the radial artery before the intervention.
Patients with stage $3 chronic kidney disease (glomer-
ular ﬁltration rate <60 mL/min) who might need a
Cimino-Brescia ﬁstula in the future were logically excluded
from our study. Also, patients who already had a functionalarteriovenous ﬁstula were not offered a radial approach to
avoid compromising ﬁstula patency.
Patients with a history of ischemic stroke secondary to
aortic arch atheroembolism were also excluded because
they might be at higher risk for navigation through the
aortic arch. The systematic use of the left radial artery
had the goal to avoid arch navigation. Despite this precau-
tion, a minor right hemispheric postoperative stroke devel-
oped in one patient after recanalization of a short SFA
occlusion. From the anatomic considerations, the reasons
for a right hemispheric stroke after LRA seem unclear.
We hypothesized that the long introducer formed a loop
in the aortic arch while trying to recanalize the SFA occlu-
sion. On the basis of this case, we now recommend a CTA
of the aortic arch before the procedure.
As have others, this case highlights the lack of axial
force when trying to cross an occlusion through transradial
access. At this time, we consider that transradial peripheral
PTA should be reserved for TASC A and B lesions and ste-
nosis rather than occlusion. Our preferred indications for
transradial peripheral PTA are summarized in Table III.
RAS was noted after the arterial puncture, in four pa-
tients, including two patients with intraoperative radial ar-
tery rupture. On the basis of our experience, RAS must be
suspected when the operator feels resistance while intro-
ducing the ﬁrst sheath or when there is no backﬂow in
the sidearm of the introducer. The exact incidence of
RAS during PCI is unclear,26 and depends on spasm deﬁ-
nition, diagnostic methods, and pharmacologic premedica-
tion. A literature review found the incidence of RAS was
evaluated to be as high as 14.7% altogether.26
As others,27 we did not routinely use intra-arterial in-
jections of vasodilators at the beginning of our experience
(ﬁrst 13 patients). Two patients presented subsequent arte-
rial rupture and lost radial artery patency. Another patient
with intraoperative spasm treated by intra-arterial injections
of vasodilators was found to have an occluded left radial ar-
tery at the 1-month visit. Although the two arterial rup-
tures might be related to our learning curve with this
technique, preserving radial artery patency is paramount
for vascular patients. Some might need radial blood pres-
sure monitoring for a major surgery in the future.
For these reasons, we now systematically perform a
2-mL isosorbide dinitrate (Risordan 10 mg/10 mL; Sanoﬁ,
Paris, France) intra-arterial injection after radial artery
JOURNAL OF VASCULAR SURGERY
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ment, a second 2-mL isosorbide dinitrate injection can
be used and possibly associated with a 2.5-mg verapamil
intra-arterial injection.26,28 In the future, smaller-proﬁle
devices speciﬁcally designed for LRA could decrease RAS
and its consequences.
We generally used LRA in our practice when the
femoral approach was precluded (Table II). We perceived
LRA as an alternative to brachial and axillary artery access
in the setting of some challenging patients where the
femoral artery was deemed inaccessible or inappropriate.
In fact, axillary artery access can necessitate a surgical cut-
down,29 and brachial access carries a certain risk of local
complications.1-5 In the largest series reporting on the
use of brachial access for aortic and peripheral procedure,1
the Cleveland Clinic team reported a 6.5% rate of access
site-related complications (pseudoaneurysm, brachial artery
thrombosis, hematoma), including a 4.0% rate of surgical
correction. Of note, conversion to open surgical closure
was needed in 2.3% cases when the artery was initially
punctured percutaneously in that series. LRA could there-
fore represent an interesting option for patients mandating
a procedure through the upper limb. Although this series
focused on lower limb PTA through LRA, the LRA could
represent an attractive option for visceral interventions30
that are often performed through the upper limb.31
Material improvements are needed to allow the wide
diffusion of this technique. To our knowledge, 110 cm is
the longest currently available introducer sheaths length.
This generally allowed landing distally within the distal
common iliac artery or the proximal external iliac artery.
However, the introducer sheath did not reach the iliac
axis in tall patients. Moreover, below-the-knee lesions
remain currently inaccessible through LRA. These points
underline the need for longer introducer sheaths and angi-
ography catheters to improve the results of PTA through
the radial artery. Anatomic studies correlating patient’s
height with the distance between vascular accesses and
target lesions could help better deﬁning material needed.
Another limit with radial access is the lack of speciﬁcally
designed rescue devices such as long-shaft covered stents
or thromboaspiration catheters.
Finally, cost-effectiveness of the technique remains to
be demonstrated. The current costs of the materials and
devices we used for transradial peripheral PTA seemed
higher than those used for femoral access. In our institu-
tion, performing a SFA angioplasty through a LRA was
associated with V393.64 (taxes excluded) extra cost for
materials compared with a femoral approach with vascular
closure device.
CONCLUSIONS
This study demonstrates the feasibility of radial access
for peripheral PTA. Radial artery access could represent
an alternative to brachial artery access for peripheral and
visceral interventions. Although complication rates of the
present series are concerning, larger series would be neces-
sary to determine the results of PTA through a radialapproach once the learning curve is overcome. Arch navi-
gation remains an issue to be solved to avoid postoperative
stroke. A wider diffusion of the technique mandates mate-
rial improvements with smaller-diameter sheaths, longer
shaft devices, and the development of speciﬁcally designed
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